Precision oncology coverage: Malaysia’s Malayan Re and China Re Life signed a treaty to build a dedicated framework for advanced cancer “precision medicine” coverage, including CAR-T and targeted immunotherapies, plus overseas treatment access in China. Care access gaps: The Palestinian Embassy in India appealed for $100M in emergency medical aid for Gaza and the West Bank, citing hospital shutdowns, shortages of key drugs and supplies, and blocked humanitarian access. Specialty surgery capacity: Asian Hospital in the Philippines opened the country’s first dedicated hernia centre, aiming to cut delays and address a major treatment gap as cases rise with an ageing population. Orthopedic infection trial: Solenic Medical got FDA IDE approval to start a pivotal U.S. trial of its non-invasive SOLA-2 system for periprosthetic joint infections. Obesity drug pipeline: Corxel reported positive Phase 2 results for CX11 (oral GLP-1) in U.S. adults, with up to 11.5% weight loss at 36 weeks, and plans for Phase 3. GI disease study: Phathom completed enrollment in a Phase 2 placebo-controlled trial of vonoprazan for eosinophilic esophagitis, with topline results expected in Q4 2026. Safety recall: FDA announced a recall of 11,460 bottles of chlorthalidone (blood pressure) tablets due to dissolution failures. Fraud crackdown: U.S. officials said Ibrahim Khaldoon Hilmi, accused in a $3.7B Medicare fraud scheme, was arrested in Türkiye and extradited to face charges. Digital health in stroke: PurpleAI and Savelife.AI went live with FDA-cleared AI stroke triage integrated into a hospital radiology workflow at White Rock Medical Center. Healthcare operations & policy: A new Medicare prior-approval pilot is testing preauthorization for certain services, raising concerns about delays and added burden for patients.